Cormorant Asset Management, LP Theravance Biopharma, Inc. Transaction History

Cormorant Asset Management, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.77 - $14.41 $2.03 Million - $4.32 Million	-300,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$14.52 - $22.46 $3.63 Million - $5.62 Million	-250,000 Reduced 45.45%	300,000 $4.36 Million
Q4 2020 Feb 16, 2021	SELL	$14.89 - $20.16 $1.49 Million - $2.02 Million	-100,072 Reduced 15.39%	550,000 $9.77 Million
Q3 2020 Nov 16, 2020	BUY	$14.79 - $22.49 $8.14 Million - $12.4 Million	550,072 Added 550.07%	650,072 $9.61 Million
Q1 2020 May 15, 2020	BUY	$17.84 - $31.21 $892,000 - $1.56 Million	50,000 Added 100.0%	100,000 $2.31 Million

Q4 2019 Feb 14, 2020	BUY	$16.12 - $25.89 $806,000 - $1.29 Million	50,000 New	50,000 $1.3 Million
Q1 2019 May 15, 2019	SELL	$22.57 - $28.15 $20 Million - $24.9 Million	-884,916 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$22.52 - $35.07 $4.84 Million - $7.54 Million	-215,084 Reduced 19.55%	884,916 $22.6 Million
Q3 2018 Nov 14, 2018	SELL	$22.83 - $32.67 $4.57 Million - $6.53 Million	-200,000 Reduced 15.38%	1,100,000 $35.9 Million
Q1 2018 May 15, 2018	BUY	$23.37 - $29.71 $9.35 Million - $11.9 Million	400,000 Added 44.44%	1,300,000 $31.5 Million
Q4 2017 Feb 14, 2018	SELL	$25.82 - $35.66 $1.29 Million - $1.78 Million	-50,000 Reduced 5.26%	900,000 $25.1 Million
Q3 2017 Nov 14, 2017	BUY	$23.88 - $34.96 $22.7 Million - $33.2 Million	950,000	950,000 $32.5 Million

124

49.6M

1.4K

2.3K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $566M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.